Author:
Li Juan,Dai Guowei,Zhang Zhuoli
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference20 articles.
1. Brummaier T, Pohanka E, Studnicka-Benke A et al (2013) Using cyclophosphamide in inflammatory rheumatic diseases. Eur J Intern Med 24:590–596
2. Sladek NE (1973) Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo. Cancer Res 33:1150–1158
3. Struck RF, Kirk MC, Witt MH et al (1975) Isolation and mass spectral identification of blood metabolites of cyclophosphamide: evidence for phosphoramide mustard as the biologically active metabolite. Biomed Mass Spectrom 2:46–52
4. Alarcon RA (1976) Studies on the in vivo formation of acrolein: 3-hydroxy-propylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation. Cancer Treat Rep 60:327–335
5. Gurtoo HL, Marinello AJ, Struck RF et al (1981) Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites. J Biol Chem 256:11691–11701
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献